Meeting
2022 ASCO Quality Care Symposium
Gastrostomy, tracheostomy, opioid, and health care utilization among patients with recurrent/metastatic head and neck cancer receiving immunotherapy.
Authors
Natalie F. Uy
University of Washington, Seattle, WA
Natalie F. Uy, Kevin Ng, Jenna M. Voutsinas, Vicky Wu, Neal D. Futran, Jeffrey Houlton, Brittany Barber, George E. Laramore, Upendra Parvathaneni, Jay Justin Liao, Cristina P. Rodriguez
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Palliative and Supportive Care,Technology and Innovation in Quality of Care,Quality, Safety, and Implementation Science
Sub Track
Symptom Prevention, Assessment, and Management
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 296)
DOI
10.1200/JCO.2022.40.28_suppl.296
Abstract #
296
Poster Bd #
G18
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Quality Care Symposium
Socioeconomic factors and outcomes among patients with recurrent/metastatic head and neck cancer receiving immunotherapy.
First Author: Natalie F. Uy
Poster
2022 ASCO Annual Meeting
The effect of opioids on the efficacy of immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC).
First Author: Nicole N Scheff
Poster
2021 ASCO Annual Meeting
Outcomes of immunotherapy (ICI) alone vs tyrosine kinase inhibitors (TKI) alone versus ICI and TKI combined in renal cell carcinoma brain metastasis.
First Author: Patrick Joseph O'Shea
Poster
2021 ASCO Annual Meeting
Proton pump inhibitors and antibiotics impact on toxicities and clinical outcomes in cancer patients treated with immunotherapy.
First Author: Haniel alves Araujo